Shuibing Liu

Dr. Shuibing Liu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2026 in Animals
Verified
Journal Article
Open access
PDF file
CLChuan Li
Chuan Li
JWJintao Wu
Jintao Wu
SLShuibing Liu
Shuibing Liu
WZWentao Zhang
Wentao Zhang
JLJing Liu
Jing Liu
BCBiao Chen
Biao Chen
N6-methyladenosine (m6A) is a reversible RNA modification that dynamically regulates gene expression by modulating RNA stability, splicing, nuclear export, translation, and maturation—thereby orchestrating organismal development. In birds, including geese, the liver is a multi-functional organ central to metabolic regulation. Studies on the dynamic patterns of RNA m6A modifications during healthy liver growth and development remain limited. Here, we performed integrative methylated RNA immunoprecipitation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) on liver tissues from geese at three biologically defined stages: post-hatch day 0 (0 week, P), fast growth (10 weeks, F), and sexual maturation (30 weeks, S). The level of m6A modification in total RNA extracted from liver tissues was higher in P than in F samples. Compared with other groups, the S group recorded the lowest m6A modification. In addition, 1641, 668, and 558 m6A peaks were differentially modified in the P, F, and S groups, respectively. The m6A peaks in the liver of the three groups were mainly enriched in the coding sequence and 3′ untranslated region. Moreover, integrated multi-omics analysis (MeRIP-seq and RNA-seq), combined with protein–protein interaction networks analysis, identified CDK1 as a core cell cycle regulator and IGF2BP3—a well-established m6A reader—as a consistently differentially expressed gene across all developmental stages. The m6A-regulated cell cycle, p53 signaling pathway, and pyrimidine metabolism pathway were identified in liver tissue as novel potential targets for controlling geese growth and metabolism. Together, these findings shed light on the dynamic regulation of RNA methylation during distinct growth phases in geese and advance our understanding of epigenetic mechanisms underlying poultry liver development.

12 October 2026 in Animals
Verified
Journal Article
Open access
PDF file
ZQZijian Qin
Zijian Qin
HLHan Lisha
Han Lisha
FYFen Ying
Fen Ying
MPMing Pan
Ming Pan
CZChangbin Zhao
Changbin Zhao
HLHongmei Li
Hongmei Li
In this study, the objective was to identify the key regulators of the osteogenic–adipogenic differentiation equilibrium of chicken bone marrow mesenchymal stem cells (BMSCs), with the expectation of developing marker genes that promote skeletal development and inhibit excessive fat deposition. BMSCs were isolated and phenotypically characterized. qRT-PCR showed FHL2 increased during osteogenic differentiation. Transfection with FHL2 overexpression plasmid or siRNAs was done. FHL2 overexpression increased osteogenic marker mRNA (RUNX2, ALP, Osterix, and OCN) levels, reduced lipid deposition-related gene (C/EBPα, C/EBPβ) expression, and increased mineralized area and nodules. FHL2 knockdown had the opposite effect. FHL2 overexpression also reduced apoptosis and proliferation-related transcripts, decreased apoptosis rate, and reduced proliferation-related transcripts and altered cell-cycle distribution. After FHL2 knockdown, RNA sequencing identified 81 differentially expressed genes. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment showed changes in various processes and pathways. Enrichment analysis indicated that the differentially expressed genes were involved in apoptosis, cytokine–cytokine receptor interaction, Th17 cell differentiation, JAK-STAT signaling, cAMP signaling, steroid hormone biosynthesis, and retinol metabolism. These findings indicate that FHL2 promotes osteogenic differentiation and suppresses adipogenic differentiation in chicken BMSCs in vitro and may act through multiple downstream pathways.